Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study - Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Srinivasan, Subramaniam; Pushkala, Subramanian; Bharatidasan, Sudhakar S.; Ikewaki, Nobunao; Iwasaki, Masaru; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel J.K. (IBRO neuroscience reports, 2023)
Keywords: Beta glucan; Disease modifying agent; Duchenne muscular dystrophy; Dystrophin; Fibrosis; Inflammation; N-163; Short Communication; NSAA; Beta glucan; CK; Inflammation; LeCR; NASH; 6MWT; N-163; LGMD; TNF-α; NLR; Disease modifying agent; Duchenne muscular dystrophy; Fibrosis; DMD; LCR; Dystrophin; MRC